New York, February 23, 2017-- Moody's Investors Service assigned a Baa3 rating to Abbott Laboratories' proposed new senior unsecured note offering. The rating outlook is stable. There are no changes to ...
Abbott Labs completed the acquisition of St. Jude Medical in January.
ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||45.23 - 45.68|
|52 Week Range||36.76 - 45.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||48.75|
|Dividend & Yield||1.06 (2.36%)|
|1y Target Est||N/A|